Alembic Pharmaceuticals secures final approval from FDA for hypertension drug
Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP, in strengths ... Read More
Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer
Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who will handle global research and development works ... Read More
AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan
US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following receipt of all the required approvals from ... Read More
AbbVie acquisition of Allergan gets antitrust clearance from US FTC
AbbVie acquisition of Allergan update : US biopharma company AbbVie has secured clearance from the US Federal Trade Commission (FTC) for its previously announced $63 ... Read More
Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma ... Read More
Allergan bags Ubrelvy FDA approval for migraine treatment
Ubrelvy FDA approval : Irish pharma company Allergan has bagged approval from the US Food and Drug Administration (FDA) for Ubrelvy (ubrogepant) tablets for the ... Read More
Amgen, Allergan file BLA to FDA for Rituxan biosimilar ABP 798
Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food ... Read More
Almirall completes $550m acquisition of five dermatology brands from Allergan
In a significant move within the pharmaceutical industry, Spanish pharmaceutical company Almirall has finalised its $550 million acquisition of five dermatology medications from Allergan's Medical ... Read More
Allergan to acquire Bonti in strategic $195m deal to expand medical aesthetics pipeline
Irish pharmaceutical giant Allergan has announced its acquisition of Bonti, a U.S.-based aesthetic company specializing in fast-acting neurotoxin programs for aesthetic and therapeutic applications. The ... Read More
Allergan announces job cuts as part of cost-reduction strategy
Allergan, globally recognized for its Botox cosmetic injections, has revealed plans to eliminate more than 1,000 jobs across its operations. This move is part of ... Read More